Loading…
Loading…
In person · Pittsburgh · PA · United States
Research provider: Pitt+Me
Is your Hidradenitis Suppurativa causing painful lumps on your body? If so, you might want to explore the COMPASS 2-HS Study on the Clinago platform! People diagnosed for 1+ years and have at least 5 HS lesions in two or more areas of their body may be eligible. Study participation will last approximately 40 weeks and includes up to 22 visits. Compensation is provided.
During the study, all participants will receive both BFB759 and a placebo (placebo looks like BFB759 but has no active ingredient). Participants will be randomly assigned to receive either BFB759 or the placebo for the first 16 weeks. After this period, they will switch and receive the other treatment for the next 16 weeks. Neither the participants nor the study team will know who is receiving the actual study medication and who is receiving the placebo. Screening (2-4 weeks) - Participants are screened for eligibility to participate in the trial Treatment (30 weeks) Bi-weekly visits - Participants receive BFB759 or placebo for 14 weeks, followed by re-randomization for continued treatment through Week 30 Follow-up (6-10 weeks) - Participants are monitored for safety and effectiveness after treatment
Is your Hidradenitis Suppurativa causing painful lumps on your body? If so, you might want to explore the COMPASS 2-HS Study on the Clinago platform! People diagnosed for 1+ years and have at least 5 HS lesions in two or more areas of their body may be eligible. Study participation will last approximately 40 weeks and includes up to 22 visits. Compensation is provided.
Review the provider’s screening questions. These requirements do not guarantee selection.